Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US Government Keeps Lights On But Pharma Priorities For PBM Reform, Rare Diseases Nixed
Dec 21 2024
•
By
Sarah Karlin-Smith
Congress narrowly avoided a government shutdown, but pharma priorities were cut from the bill.
(Shutterstock)
More from Legislation
More from Rare Diseases